Travere Therapeutics, Inc. (TVTX)
USD 15.0
(-9.42%)
USD 15.0
(-9.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 788.91 Million USD | 17.3% |
| 2022 | 672.58 Million USD | -13.4% |
| 2021 | 776.63 Million USD | 27.85% |
| 2020 | 607.43 Million USD | 0.44% |
| 2019 | 604.8 Million USD | -14.72% |
| 2018 | 709.16 Million USD | 36.29% |
| 2017 | 520.34 Million USD | -0.94% |
| 2016 | 525.28 Million USD | 2.51% |
| 2015 | 512.4 Million USD | 278.24% |
| 2014 | 135.47 Million USD | 560.87% |
| 2013 | 20.49 Million USD | 757.24% |
| 2012 | 2.39 Million USD | 61073.32% |
| 2011 | 3909.00 USD | -1.24% |
| 2010 | 3958.00 USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 4771.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 551.12 Million USD | -16.94% |
| 2024 Q1 | 663.54 Million USD | -15.89% |
| 2024 Q3 | 504.41 Million USD | -8.48% |
| 2023 Q4 | 788.91 Million USD | -5.28% |
| 2023 Q1 | 808.23 Million USD | 20.17% |
| 2023 FY | 788.91 Million USD | 17.3% |
| 2023 Q3 | 832.85 Million USD | 13.09% |
| 2023 Q2 | 736.42 Million USD | -8.88% |
| 2022 Q3 | 726.21 Million USD | -6.84% |
| 2022 Q1 | 828.4 Million USD | 6.67% |
| 2022 Q2 | 779.49 Million USD | -5.9% |
| 2022 Q4 | 672.58 Million USD | -7.38% |
| 2022 FY | 672.58 Million USD | -13.4% |
| 2021 Q2 | 746.76 Million USD | -2.26% |
| 2021 FY | 776.63 Million USD | 27.85% |
| 2021 Q1 | 764.04 Million USD | 25.78% |
| 2021 Q3 | 775.07 Million USD | 3.79% |
| 2021 Q4 | 776.63 Million USD | 0.2% |
| 2020 Q4 | 607.43 Million USD | -12.25% |
| 2020 Q1 | 573.06 Million USD | -5.25% |
| 2020 FY | 607.43 Million USD | 0.44% |
| 2020 Q2 | 678.69 Million USD | 18.43% |
| 2020 Q3 | 692.22 Million USD | 1.99% |
| 2019 Q3 | 613.81 Million USD | -5.21% |
| 2019 FY | 604.8 Million USD | -14.72% |
| 2019 Q1 | 667.66 Million USD | -5.85% |
| 2019 Q2 | 647.57 Million USD | -3.01% |
| 2019 Q4 | 604.8 Million USD | -1.47% |
| 2018 Q1 | 500.79 Million USD | -3.76% |
| 2018 Q4 | 709.16 Million USD | -0.98% |
| 2018 Q3 | 716.18 Million USD | 45.82% |
| 2018 FY | 709.16 Million USD | 36.29% |
| 2018 Q2 | 491.14 Million USD | -1.93% |
| 2017 Q3 | 520.51 Million USD | 2.64% |
| 2017 Q1 | 510.38 Million USD | -2.84% |
| 2017 Q2 | 507.13 Million USD | -0.64% |
| 2017 FY | 520.34 Million USD | -0.94% |
| 2017 Q4 | 520.34 Million USD | -0.03% |
| 2016 Q3 | 532.42 Million USD | -0.29% |
| 2016 FY | 525.28 Million USD | 2.51% |
| 2016 Q2 | 533.97 Million USD | 5.3% |
| 2016 Q4 | 525.28 Million USD | -1.34% |
| 2016 Q1 | 507.1 Million USD | -1.03% |
| 2015 FY | 512.4 Million USD | 278.24% |
| 2015 Q1 | 415.98 Million USD | 207.07% |
| 2015 Q2 | 425.14 Million USD | 2.2% |
| 2015 Q3 | 511.63 Million USD | 20.34% |
| 2015 Q4 | 512.4 Million USD | 0.15% |
| 2014 Q4 | 135.47 Million USD | -7.17% |
| 2014 FY | 135.47 Million USD | 560.87% |
| 2014 Q3 | 145.93 Million USD | -6.17% |
| 2014 Q2 | 155.53 Million USD | 65.38% |
| 2014 Q1 | 94.04 Million USD | 358.8% |
| 2013 Q3 | 21.36 Million USD | 699.42% |
| 2013 Q1 | 4.95 Million USD | 126839.51% |
| 2013 Q4 | 20.49 Million USD | -4.05% |
| 2013 FY | 20.49 Million USD | 757.24% |
| 2013 Q2 | 2.67 Million USD | -46.02% |
| 2012 Q4 | 3900.00 USD | 0.0% |
| 2012 FY | 2.39 Million USD | 61073.32% |
| 2012 Q1 | 3909.00 USD | 0.46% |
| 2012 Q2 | 3900.00 USD | -0.23% |
| 2012 Q3 | 3900.00 USD | 0.0% |
| 2011 Q2 | 3934.00 USD | -0.61% |
| 2011 Q1 | 3958.00 USD | 0.0% |
| 2011 FY | 3909.00 USD | -1.24% |
| 2011 Q4 | 3891.00 USD | -0.46% |
| 2011 Q3 | 3909.00 USD | -0.64% |
| 2010 FY | 3958.00 USD | 0.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q2 | 4629.00 USD | 0.0% |
| 2010 Q3 | 4629.00 USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | 4666.00 USD | -0.38% |
| 2009 Q3 | 4684.00 USD | -1.43% |
| 2009 Q2 | 4752.00 USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | 5000.00 USD | 0.0% |
| 2008 Q3 | - USD | -100.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | 4771.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | 46.985% |
| Alkermes plc | 2.13 Billion USD | 63.07% |
| Agenus Inc. | 313.91 Million USD | -151.316% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 79.401% |
| Aptorum Group Limited | 20.64 Million USD | -3722.236% |
| Ardelyx, Inc. | 297.57 Million USD | -165.11% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -3.052% |
| Bicycle Therapeutics plc | 595.34 Million USD | -32.514% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -970.409% |
| ChromaDex Corporation | 54.96 Million USD | -1335.327% |
| Chimerix, Inc. | 212.77 Million USD | -270.775% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -2690.401% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -78.905% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 64.616% |
| Precision BioSciences, Inc. | 159.78 Million USD | -393.746% |
| Dyadic International, Inc. | 8.21 Million USD | -9498.374% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -2385.548% |
| Fortress Biotech, Inc. | 167.52 Million USD | -370.92% |
| Lantern Pharma Inc. | 43.64 Million USD | -1707.46% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -388.985% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -5338.286% |
| Incyte Corporation | 6.78 Billion USD | 88.368% |
| IO Biotech, Inc. | 150.71 Million USD | -423.436% |
| Jaguar Health, Inc. | 50.76 Million USD | -1454.11% |
| Novavax, Inc. | 1.85 Billion USD | 57.479% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -107.387% |
| Opthea Limited | 188.79 Million USD | -317.876% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | 5.3% |
| ContextLogic Inc. | 423 Million USD | -86.504% |
| MiMedx Group, Inc. | 239.04 Million USD | -230.024% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -354.113% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -15160.322% |
| NextCure, Inc. | 129.41 Million USD | -509.585% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -1362.358% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -2047.929% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -2342.379% |
| Vaxcyte, Inc. | 1.4 Billion USD | 43.966% |
| PDS Biotechnology Corporation | 59.39 Million USD | -1228.358% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -23.162% |
| Pharming Group N.V. | 462.85 Million USD | -70.445% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -1939.589% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -25.512% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -4068.921% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -4068.921% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -377.204% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -1642.03% |
| Acelyrin, Inc. | 742.69 Million USD | -6.224% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -11877.685% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -12220.99% |
| Summit Therapeutics Inc. | 202.94 Million USD | -288.725% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -960.738% |
| Senti Biosciences, Inc. | 119.48 Million USD | -560.267% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -245.496% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -369.105% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -9447.537% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -16426.002% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -68.143% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -538.006% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -186.931% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -66.846% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -7707.155% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -267.781% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -69582.174% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -90.631% |
| Immix Biopharma, Inc. | 19.92 Million USD | -3859.381% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -113.205% |
| MEI Pharma, Inc. | 41.37 Million USD | -1806.738% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -2334.466% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -131.49% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -572.99% |
| Fortress Biotech, Inc. | 167.52 Million USD | -370.92% |
| Precigen, Inc. | 151.04 Million USD | -422.31% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -2219.105% |
| AlloVir, Inc. | 190.79 Million USD | -313.485% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -109.566% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -55.845% |
| ImmuCell Corporation | 43.8 Million USD | -1700.838% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -21.499% |
| Onconetix, Inc. | 88.82 Million USD | -788.201% |
| PureTech Health plc | 693.97 Million USD | -13.681% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -707.609% |
| Elevation Oncology, Inc. | 89.09 Million USD | -785.514% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -12620.3% |
| Seer, Inc. | 436.26 Million USD | -80.832% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -866.841% |
| Innoviva, Inc. | 1.24 Billion USD | 36.557% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -495.752% |
| ESSA Pharma Inc. | 149.12 Million USD | -429.038% |
| GlycoMimetics, Inc. | 45.31 Million USD | -1640.897% |
| GT Biopharma, Inc. | 14.1 Million USD | -5491.559% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -156.23% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -226.398% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -67.176% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -1456.133% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -728.586% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -124809.435% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -39.3% |
| Aptose Biosciences Inc. | 12.92 Million USD | -6004.936% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -3467.436% |
| Soligenix, Inc. | 9.79 Million USD | -7952.33% |
| Century Therapeutics, Inc. | 360.69 Million USD | -118.723% |
| Kura Oncology, Inc. | 448.93 Million USD | -75.73% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -189.883% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -4461.509% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -611.301% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -284.552% |
| Autolus Therapeutics plc | 375.38 Million USD | -110.163% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -213.514% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -122.114% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -1505.701% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -19.327% |
| GRI Bio, Inc. | 2.95 Million USD | -26588.532% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -7338.908% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -362.665% |
| IGM Biosciences, Inc. | 423.41 Million USD | -86.323% |
| INmune Bio, Inc. | 57 Million USD | -1284.034% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -254.558% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -839.839% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -2920.704% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -11361.436% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -948.724% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -435.735% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -376.673% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -25.303% |
| Verastem, Inc. | 149.71 Million USD | -426.933% |
| Abeona Therapeutics Inc. | 64 Million USD | -1132.638% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -54.038% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -410.765% |
| Histogen Inc. | 19.07 Million USD | -4036.282% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -3383.033% |
| Surrozen, Inc. | 46.08 Million USD | -1612.051% |
| Organovo Holdings, Inc. | 6.34 Million USD | -12325.784% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -18210.109% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -447.754% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -6584.57% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -948.139% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -9160.357% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -117.35% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -4259.985% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -83.724% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -6155.396% |
| Apollomics, Inc. | 55.38 Million USD | -1324.365% |
| Amarin Corporation plc | 831.68 Million USD | 5.143% |
| Mesoblast Limited | 669.15 Million USD | -17.897% |
| Turnstone Biologics Corp. | 112.81 Million USD | -599.298% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -37.021% |
| Synaptogenix, Inc. | 31.11 Million USD | -2435.583% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -6374.992% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -43.946% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -13334.57% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -10640.584% |
| Exelixis, Inc. | 2.94 Billion USD | 73.188% |
| Better Therapeutics, Inc. | 22.94 Million USD | -3338.578% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -116.414% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -0.023% |
| NLS Pharmaceutics AG | 1.84 Million USD | -42621.514% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -9787.82% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -5268.581% |
| Gritstone bio, Inc. | 177.76 Million USD | -343.785% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -727.126% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -4316.645% |
| Avid Bioservices, Inc. | 336.55 Million USD | -134.407% |
| Insmed Incorporated | 1.32 Billion USD | 40.676% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -8093.651% |
| MediWound Ltd. | 66.45 Million USD | -1087.067% |
| OmniAb, Inc. | 401.98 Million USD | -96.254% |
| Alector, Inc. | 621.82 Million USD | -26.87% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -119.998% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -14569.264% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -1291.577% |
| Zai Lab Limited | 1.03 Billion USD | 23.872% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -64.888% |
| Aura Biosciences, Inc. | 255.07 Million USD | -209.287% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -5.184% |
| Immunic, Inc. | 54.29 Million USD | -1352.905% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -196.334% |
| Veracyte, Inc. | 1.13 Billion USD | 30.665% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -6572.82% |
| FibroGen, Inc. | 423.52 Million USD | -86.271% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -22356.96% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -16555.664% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -14430.181% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 93.076% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -8859.83% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -52.461% |
| TG Therapeutics, Inc. | 329.58 Million USD | -139.364% |
| Galecto, Inc. | 38.22 Million USD | -1963.759% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -2651.126% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 81.894% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -235.132% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -3075.723% |
| XBiotech Inc. | 227.24 Million USD | -247.167% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -727.126% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -453.235% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -175.925% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -516.97% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -106.522% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | 47.089% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -116.234% |
| Vaxxinity, Inc. | 44.35 Million USD | -1678.714% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -52.606% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -4139.341% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -158.618% |
| NexImmune, Inc. | 8.59 Million USD | -9079.866% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -7262.567% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -4506.148% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 97.615% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -3461.502% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -201017.357% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -355.153% |
| Ainos, Inc. | 31.84 Million USD | -2377.601% |
| Pluri Inc. | 39.52 Million USD | -1895.884% |
| Prothena Corporation plc | 696.38 Million USD | -13.287% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -179.147% |
| Celularity Inc. | 143.88 Million USD | -448.279% |
| Rallybio Corporation | 115.62 Million USD | -582.333% |
| Cue Biopharma, Inc. | 61.53 Million USD | -1182.16% |
| MeiraGTx Holdings plc | 458.16 Million USD | -72.189% |
| Omeros Corporation | 378.26 Million USD | -108.559% |
| Humacyte, Inc. | 128.22 Million USD | -515.266% |
| Immunocore Holdings plc | 597 Million USD | -32.146% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -2423.795% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -1051.194% |
| Blueprint Medicines Corporation | 1.04 Billion USD | 24.812% |
| CalciMedica, Inc. | 12.18 Million USD | -6374.46% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -211.024% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -361.601% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -153.641% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -39.557% |
| Pulmatrix, Inc. | 33.95 Million USD | -2223.202% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -2806.185% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -460.077% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | 39.36% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -505.975% |
| Cytokinetics, Incorporated | 824.31 Million USD | 4.295% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -3634.853% |
| Nutriband Inc. | 7.51 Million USD | -10394.836% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -899.206% |
| Vor Biopharma Inc. | 209.82 Million USD | -275.981% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 89.077% |
| Evogene Ltd. | 51.1 Million USD | -1443.831% |
| ProKidney Corp. | 420.55 Million USD | -87.59% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -1338.756% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -8186.659% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -44.389% |
| CorMedix Inc. | 82.05 Million USD | -861.386% |
| BioLineRx Ltd. | 63.92 Million USD | -1134.123% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -95.971% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -2697.564% |
| Atai Life Sciences N.V. | 293.47 Million USD | -168.815% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -383.612% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -519.153% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -40.369% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -715.675% |
| MediciNova, Inc. | 66.26 Million USD | -1090.453% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -797.022% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -17579.258% |
| GeoVax Labs, Inc. | 9.28 Million USD | -8398.27% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -34.115% |
| Biomea Fusion, Inc. | 199.92 Million USD | -294.601% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | 58.548% |
| Mereo BioPharma Group plc | 66.49 Million USD | -1086.353% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -62.63% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -28.722% |
| Absci Corporation | 234.48 Million USD | -236.452% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -10684.867% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -132.108% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -377.892% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -49.892% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -184.095% |
| Allakos Inc. | 243.61 Million USD | -223.843% |
| Imunon, Inc. | 21.91 Million USD | -3499.373% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -206.143% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -26.933% |
| BioAtla, Inc. | 119.65 Million USD | -559.307% |
| NLS Pharmaceutics AG | 1.84 Million USD | -42621.514% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -24400.404% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -22.724% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -722.341% |
| XOMA Corporation | 234.3 Million USD | -236.709% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -256.595% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -526.898% |
| aTyr Pharma, Inc. | 122.06 Million USD | -546.295% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -412.604% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -35.956% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -60.863% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -614.149% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -5104.75% |
| Akari Therapeutics, Plc | 4.35 Million USD | -18015.109% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -4530.496% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | 54.484% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -25480.953% |
| UroGen Pharma Ltd. | 178.31 Million USD | -342.437% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -67.591% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -141863.596% |
| Orgenesis Inc. | 14.55 Million USD | -5321.337% |
| Entera Bio Ltd. | 11.76 Million USD | -6605.593% |
| GH Research PLC | 226.3 Million USD | -248.614% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -1342.412% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -634.31% |
| Xencor, Inc. | 952.69 Million USD | 17.191% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -10035.357% |
| Replimune Group, Inc. | 487.72 Million USD | -61.755% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -9674.555% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -21.663% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -25480.953% |
| Portage Biotech Inc. | 7.77 Million USD | -10041.573% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -17579.258% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -184.863% |
| OncoCyte Corporation | 74.89 Million USD | -953.401% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -38700.628% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -13533.345% |
| Purple Biotech Ltd. | 44.3 Million USD | -1680.762% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -2211.765% |
| scPharmaceuticals Inc. | 94.47 Million USD | -735.014% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -4271.93% |
| HilleVax, Inc. | 344.43 Million USD | -129.046% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -24739.83% |
| Tharimmune, Inc. | 10.94 Million USD | -7107.059% |
| Genprex, Inc. | 10.67 Million USD | -7293.339% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -58.993% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -719.633% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -32419.085% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -18839.483% |
| OKYO Pharma Limited | 1.54 Million USD | -51086.104% |
| Savara Inc. | 177.56 Million USD | -344.298% |
| Curis, Inc. | 77.28 Million USD | -920.824% |
| Daré Bioscience, Inc. | 21.28 Million USD | -3606.912% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -1133.663% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -9656.53% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -3972.65% |
| BeiGene, Ltd. | 5.8 Billion USD | 86.41% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -6382.973% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 62.228% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -120.397% |
| Erasca, Inc. | 395.29 Million USD | -99.575% |
| bluebird bio, Inc. | 619.16 Million USD | -27.416% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -18147.644% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 88.469% |
| DBV Technologies S.A. | 182.98 Million USD | -331.133% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -18147.644% |
| Moderna, Inc. | 18.42 Billion USD | 95.718% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -4230.642% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -6709.192% |
| Molecular Templates, Inc. | 35.38 Million USD | -2129.639% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -470.58% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -159.72% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -658.964% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -69.43% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -151.697% |
| MacroGenics, Inc. | 306.82 Million USD | -157.126% |
| RenovoRx, Inc. | 1.46 Million USD | -53713.984% |
| Adicet Bio, Inc. | 207.29 Million USD | -280.575% |
| Prime Medicine, Inc. | 193.85 Million USD | -306.969% |
| Aditxt, Inc. | 44.57 Million USD | -1669.723% |
| Adagene Inc. | 115.72 Million USD | -581.691% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -17611.709% |
| Quantum-Si incorporated | 298.25 Million USD | -164.514% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | 46.962% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -10133.499% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -124.582% |
| SciSparc Ltd. | 11.18 Million USD | -6955.205% |
| Vericel Corporation | 353.65 Million USD | -123.073% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -6359.824% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -1286.475% |
| Generation Bio Co. | 374.75 Million USD | -110.513% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -209.783% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -397.527% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -131.105% |
| Invivyd, Inc. | 229.18 Million USD | -244.231% |
| Relay Therapeutics, Inc. | 843.98 Million USD | 6.525% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -6382.813% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -332.542% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -3762.676% |
| 2seventy bio, Inc. | 565.42 Million USD | -39.525% |
| ADMA Biologics, Inc. | 329.18 Million USD | -139.659% |
| Clene Inc. | 52.34 Million USD | -1407.256% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -1243.189% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -507.351% |
| GeoVax Labs, Inc. | 9.28 Million USD | -8398.27% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -20.684% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -661.417% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -505.06% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -708.71% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -1011.192% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -225.254% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 59.751% |
| Evaxion Biotech A/S | 12.88 Million USD | -6021.005% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -212.986% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -4.813% |
| Trevena, Inc. | 40.6 Million USD | -1842.896% |
| Surrozen, Inc. | 46.08 Million USD | -1612.051% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -249.298% |
| Cingulate Inc. | 3.49 Million USD | -22495.66% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -4644.2% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -1100.964% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -6651.717% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -193.804% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -5.335% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -526.659% |
| Clearmind Medicine Inc. | 4.32 Million USD | -18143.34% |
| Kronos Bio, Inc. | 213.27 Million USD | -269.897% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -393.737% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -9115.617% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -114.093% |
| Statera Biopharma, Inc. | 21.16 Million USD | -3626.617% |
| ImmunityBio, Inc. | 504.45 Million USD | -56.39% |
| Korro Bio, Inc. | 221.66 Million USD | -255.906% |
| Kineta, Inc. | 10.28 Million USD | -7573.505% |
| BioVie Inc. | 25.2 Million USD | -3029.571% |
| Codexis, Inc. | 136.56 Million USD | -477.7% |
| Celularity Inc. | 143.88 Million USD | -448.279% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -24.169% |
| Celcuity Inc. | 191.21 Million USD | -312.57% |
| Virax Biolabs Group Limited | 5.48 Million USD | -14285.803% |
| Cibus, Inc. | 544.41 Million USD | -44.911% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -526.649% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -3740.114% |
| IN8bio, Inc. | 33.7 Million USD | -2240.363% |
| Kodiak Sciences Inc. | 479.37 Million USD | -64.572% |
| Annexon, Inc. | 297.67 Million USD | -165.026% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -355.993% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -473.884% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -3657.981% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 73.616% |
| Eyenovia, Inc. | 28.77 Million USD | -2641.244% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -242.22% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -10820.723% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -1194.871% |
| Arcellx, Inc. | 825.13 Million USD | 4.389% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -866.367% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -70.659% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -2465.571% |
| Moolec Science SA | 24.05 Million USD | -3180.128% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -154.385% |
| Geron Corporation | 394.07 Million USD | -100.193% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -675.649% |
| Royalty Pharma plc | 16.38 Billion USD | 95.184% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -32.598% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -11178.54% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -6459.344% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -248.984% |
| Humacyte, Inc. | 128.22 Million USD | -515.266% |
| Structure Therapeutics Inc. | 482.01 Million USD | -63.669% |
| 89bio, Inc. | 596.26 Million USD | -32.308% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -212.872% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -42543.946% |
| Genelux Corporation | 27.89 Million USD | -2728.355% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -782.423% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -243.859% |
| Notable Labs, Ltd. | 19.54 Million USD | -3937.219% |
| Liquidia Corporation | 120.43 Million USD | -555.075% |
| Mustang Bio, Inc. | 17.74 Million USD | -4346.584% |
| Immunovant, Inc. | 666.71 Million USD | -18.329% |
| Quantum-Si incorporated | 298.25 Million USD | -164.514% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -446.335% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -1356.634% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -349.405% |
| Acasti Pharma Inc. | 73.3 Million USD | -976.28% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -17230.059% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -2920.704% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | 18.23% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -15100.876% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -3363.031% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -1428.812% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -336.609% |
| PepGen Inc. | 143.05 Million USD | -451.487% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -1964.299% |
| United Therapeutics Corporation | 7.16 Billion USD | 88.992% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -4012.134% |
| Solid Biosciences Inc. | 164.93 Million USD | -378.306% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -13334.57% |
| Immuneering Corporation | 102.58 Million USD | -669.037% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -18210.109% |
| Silo Pharma, Inc. | 7.74 Million USD | -10084.594% |
| Belite Bio, Inc | 94.64 Million USD | -733.576% |
| XOMA Corporation | 234.3 Million USD | -236.709% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -238.316% |
| Bionomics Limited | 27.64 Million USD | -2753.305% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -96.538% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -634.638% |
| uniQure N.V. | 831.68 Million USD | 5.143% |
| Cassava Sciences, Inc. | 151.66 Million USD | -420.175% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -17611.709% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -188.045% |
| Forte Biosciences, Inc. | 38.98 Million USD | -1923.892% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -19268.793% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -2041.981% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -10820.723% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -22356.96% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -6573.826% |
| Altimmune, Inc. | 210.64 Million USD | -274.531% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -1.418% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -634.638% |
| Compugen Ltd. | 121.33 Million USD | -550.199% |
| Peak Bio, Inc. | 2.59 Million USD | -30284.704% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -357.8% |
| Benitec Biopharma Inc. | 52.21 Million USD | -1411.038% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -130.771% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -2168.752% |
| Zura Bio Limited | 100.84 Million USD | -682.318% |
| PolyPid Ltd. | 15.37 Million USD | -5032.143% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -561.363% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -2168.752% |
| Instil Bio, Inc. | 325.63 Million USD | -142.273% |
| argenx SE | 4.54 Billion USD | 82.632% |
| Immunome, Inc. | 148.54 Million USD | -431.111% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -402.893% |
| Verona Pharma plc | 308.12 Million USD | -156.038% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -807.224% |
| Shattuck Labs, Inc. | 159.56 Million USD | -394.418% |
| CervoMed Inc. | 9.97 Million USD | -7810.868% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -318.619% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -6827.582% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -339.739% |
| Moolec Science SA | 24.05 Million USD | -3180.128% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -12796.045% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -356.166% |
| AnaptysBio, Inc. | 452.38 Million USD | -74.388% |
| Design Therapeutics, Inc. | 289.64 Million USD | -172.374% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -983.3% |
| NeurAxis, Inc. | 509.49 Thousand USD | -154741.236% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -14460.963% |
| Lumos Pharma, Inc. | 40.63 Million USD | -1841.318% |
| Achilles Therapeutics plc | 161.45 Million USD | -388.624% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -807.224% |
| 180 Life Sciences Corp. | 5.25 Million USD | -14899.84% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -1020.173% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -9115.617% |
| Nutriband Inc. | 7.51 Million USD | -10394.836% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -209.759% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -295.84% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -935.156% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -1262.168% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -49.83% |
| Palisade Bio, Inc. | 14.05 Million USD | -5514.24% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -275.146% |
| Beam Therapeutics Inc. | 1.45 Billion USD | 45.954% |
| Neurogene Inc. | 222.57 Million USD | -254.451% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -22.005% |
| AEON Biopharma, Inc. | 6.84 Million USD | -11425.391% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -74.139% |
| Sesen Bio, Inc. | 189.17 Million USD | -317.03% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -190.183% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -5653.504% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -1.097% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -195.48% |
| Athira Pharma, Inc. | 160.24 Million USD | -392.317% |
| Vaccinex, Inc. | 3.63 Million USD | -21627.155% |
| HCW Biologics Inc. | 28.51 Million USD | -2666.79% |
| XOMA Corporation | 234.3 Million USD | -236.709% |
| Nektar Therapeutics | 398.03 Million USD | -98.203% |
| Arvinas, Inc. | 1.3 Billion USD | 39.528% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -4530.496% |
| Merus N.V. | 458.49 Million USD | -72.066% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -286.029% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -337.789% |
| Rezolute, Inc. | 132.73 Million USD | -494.343% |
| Clene Inc. | 52.34 Million USD | -1407.256% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -5186.247% |
| BeyondSpring Inc. | 24.8 Million USD | -3080.075% |
| Synlogic, Inc. | 75.55 Million USD | -944.226% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -6550.759% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -8324.957% |
| Peak Bio, Inc. | 2.59 Million USD | -30284.704% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -351.238% |
| Krystal Biotech, Inc. | 818.35 Million USD | 3.598% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -228.115% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -8.697% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -21954.085% |
| MannKind Corporation | 475.19 Million USD | -66.018% |
| Ikena Oncology, Inc. | 192.09 Million USD | -310.695% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -5798.856% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -576.952% |
| Gossamer Bio, Inc. | 311.91 Million USD | -152.925% |
| CohBar, Inc. | 16.36 Million USD | -4720.537% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -2143.588% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -10684.867% |
| Legend Biotech Corporation | 1.84 Billion USD | 57.324% |
| Mural Oncology plc | 301.74 Million USD | -161.45% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -2427.352% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -13788.323% |
| Disc Medicine, Inc. | 367.99 Million USD | -114.381% |
| Champions Oncology, Inc. | 26.13 Million USD | -2918.954% |
| REGENXBIO Inc. | 573.97 Million USD | -37.448% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -29031.767% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -411.0% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -6433.127% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -132.009% |
| Vaxart, Inc. | 91.83 Million USD | -759.102% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -1216.965% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -431.874% |
| Cellectis S.A. | 334.27 Million USD | -136.011% |
| Longeveron Inc. | 12.17 Million USD | -6378.182% |
| Repare Therapeutics Inc. | 253.9 Million USD | -210.717% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 75.834% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -292.793% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 62.228% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -48448.492% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -184.077% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -383.705% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -468.611% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -2991.11% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 96.529% |
| Denali Therapeutics Inc. | 1.15 Billion USD | 31.632% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -6359.824% |
| Veru Inc. | 50.59 Million USD | -1459.242% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -1631.857% |
| Cingulate Inc. | 3.49 Million USD | -22495.66% |
| Passage Bio, Inc. | 150.54 Million USD | -424.038% |
| Context Therapeutics Inc. | 16.06 Million USD | -4811.449% |
| Exicure, Inc. | 11.58 Million USD | -6712.72% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -109.791% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -388.062% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -4415.299% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -137.092% |
| Nuvalent, Inc. | 732.38 Million USD | -7.718% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -5179.101% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -780.936% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -5459.249% |
| OmniAb, Inc. | 401.98 Million USD | -96.254% |
| Anew Medical, Inc. | 19.45 Million USD | -3954.867% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -2851.795% |
| Lipocine Inc. | 23 Million USD | -3329.897% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -464.287% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -158.182% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -839.839% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -549.097% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -9842.193% |
| Sage Therapeutics, Inc. | 882.27 Million USD | 10.582% |
| Ocugen, Inc. | 64.54 Million USD | -1122.23% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -533.456% |
| Q32 Bio Inc. | 306.11 Million USD | -157.714% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -18647.933% |
| Alumis Inc. Common Stock | 89.61 Million USD | -780.365% |
| Equillium, Inc. | 50.53 Million USD | -1461.276% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -949.156% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -1811.426% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -46283.374% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -2917.914% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -1124.241% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -21066.866% |
| Dominari Holdings Inc. | 57.55 Million USD | -1270.64% |
| Edesa Biotech, Inc. | 8.89 Million USD | -8773.726% |
| vTv Therapeutics Inc. | 11.01 Million USD | -7060.22% |
| Bio-Techne Corporation | 2.81 Billion USD | 71.957% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | 15.815% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | 2.777% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -184.124% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -1791.787% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -18.174% |
| Nkarta, Inc. | 378.88 Million USD | -108.22% |
| BioCardia, Inc. | 2.98 Million USD | -26311.55% |
| Iterum Therapeutics plc | 26.25 Million USD | -2904.353% |